Ken Seamon

Visiting Scientist CRUK Cambridge Centre

Greater Cambridge Area

About

Experience

  • Director of Scientific Development and Global Collaboration at CRUK Cambridge Cancer Centre, University of Cambridge
    Oct 2011 - Feb 2024 · 12 yrs 5 mos

  • Affiliate Lecturer, Department of Chemical Engineering and Biotechnology at University of Cambridge
    Jan 2007 - Oct 2020 · 13 yrs 10 mos

  • Vice President, Regulatory Affairs, CMC at Amgen
    Jul 2002 - Dec 2005 · 3 yrs 6 mos

    Responsible for global regulatory affairs for manufacturing and product development. Responsible for developing and advocating science based positions for a number of global issues with regard to government regulation of biopharmaceutical products

  • Sr. Vice President, Drug Development at Immunex Corporation
    Feb 1996 - Jul 2002 · 6 yrs 6 mos

    Responsible for regulatory affairs, quality assurance, quality control, drug surveillance, and pharmacology/toxicology including a staff of about 400 with multiple development and commercial manufacturing facilities.

  • FDA (13 yrs 2 mos)
    • Associate Director for Research, Center for Biologics Evaluation and Research
      Jun 1992 - Feb 1996 · 3 yrs 9 mos

      Responsible for coordination of research across three products related Offices of Vaccines, Blood, and Therapeutics which includes 9 research divisions and approximately 300 research staff. Manages the Center advisory committee programs, peer review process for research scientists, and represents the Center as an expert for biotechnology quality issues.

    • Chief Molecular Pharmacology Department, Center for Biologics Evaluation and Research
      Nov 1987 - Feb 1996 · 8 yrs 4 mos

      Supervise the research and regulatory activities of the senior staff, postdoctoral fellows, and technicians in the laboratory. Plan the budget, allocate space and resources for the laboratory. Direct supervision of the research activities of postdoctoral fellows and technicians carrying out basic research in second messenger regulation and interactions of small ligands with membrane transport proteins. These studies address the regulation of hormone sensitive adenylyl cyclase, facilitated glucose transporters, and the multidrug transporter P-glycoprotein. Administrative supervision of research programs that are being conducted by independent staff investigators in the Laboratory. These programs encompass the areas of oligonucleotide synthesis and developmental biology. Supervision and management of facility for the production and purification of synthetic peptides, use of peptides for antibody development, and separation and sequencing of biologically relevant proteins and peptides. Review INDs, serve on licensing committees, and lead inspections of biotechnology manufacturing facilities. Train inspectors for the cGMP inspections for biotechnology manufacturing facilities and serve as a biochemical expert on working groups and task force at the Center and FDA. Oversee training and regulatory activities of staff in the laboratory regarding growth factors, monoclonal antibodies, synthetic peptides, and other products.

    • Acting Director, Office of Therapeutics Research and Review
      Jun 1994 - Jul 1995 · 1 yr 2 mos

      Responsibility for a staff of 240 in four product research divisions, one clinical trial review division, and an application division. Responsible for supervising the regulatory and research activities of product related divisions of monoclonal antibodies, cellular and gene therapy, monoclonal antibodies, and hematologic products; the clinical trial design and analysis division, and the applications division.